RBC Capital Downgrades Quest Diagnostics (DGX) to Sector Perform
Tweet
Share
E-mailGet Alerts DGX Hot Sheet
Price: $235.46 -0.02%
Rating Summary:
15 Buy, 17 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 98
Rating Summary:
15 Buy, 17 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 98
Join SI Premium – FREE
RBC Capital downgraded Quest Diagnostics (NYSE: DGX) from Outperform to Sector Perform. PT lowered from $67 to $61.
For more ratings news on Quest Diagnostics click here and for the rating history of Quest Diagnostics click here.
Shares of Quest Diagnostics closed at $58.36 yesterday.
For more ratings news on Quest Diagnostics click here and for the rating history of Quest Diagnostics click here.
Shares of Quest Diagnostics closed at $58.36 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Quest Diagnostics (DGX) PT Raised to $245 at UBS
- Evercore ISI Downgrades Chewy Inc. (CHWY) to In Line, 'Back on the Leash'
- Macquarie Downgrades Mercari, Inc (4385:JP) (MRCIF) to Neutral
Create E-mail Alert Related Categories
DowngradesRelated Entities
RBC CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
